A detailed history of New York State Common Retirement Fund transactions in Rx Sight, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 221,711 shares of RXST stock, worth $9.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
221,711
Previous 128,377 72.7%
Holding current value
$9.79 Million
Previous $7.72 Million 41.88%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$40.78 - $57.04 $3.81 Million - $5.32 Million
93,334 Added 72.7%
221,711 $11 Million
Q2 2024

Jul 31, 2024

BUY
$50.42 - $64.29 $537,678 - $685,588
10,664 Added 9.06%
128,377 $7.72 Million
Q1 2024

May 07, 2024

SELL
$35.51 - $57.92 $629,414 - $1.03 Million
-17,725 Reduced 13.09%
117,713 $6.07 Million
Q4 2023

Feb 01, 2024

BUY
$20.91 - $40.9 $580,419 - $1.14 Million
27,758 Added 25.78%
135,438 $5.46 Million
Q3 2023

Nov 07, 2023

BUY
$27.05 - $33.37 $380,241 - $469,082
14,057 Added 15.01%
107,680 $3 Million
Q2 2023

Aug 07, 2023

SELL
$16.37 - $28.9 $340,790 - $601,640
-20,818 Reduced 18.19%
93,623 $2.7 Million
Q1 2023

May 02, 2023

BUY
$12.58 - $16.68 $1.29 Million - $1.7 Million
102,147 Added 830.87%
114,441 $1.91 Million
Q4 2022

Jan 30, 2023

BUY
$9.93 - $14.2 $39 - $56
4 Added 0.03%
12,294 $156,000
Q3 2022

Nov 08, 2022

BUY
$11.19 - $15.85 $537 - $760
48 Added 0.39%
12,290 $147,000
Q2 2022

Aug 04, 2022

BUY
$10.61 - $16.66 $604 - $949
57 Added 0.47%
12,242 $172,000
Q1 2022

May 05, 2022

BUY
$8.97 - $14.03 $74,567 - $116,631
8,313 Added 214.7%
12,185 $151,000
Q4 2021

Feb 02, 2022

BUY
$9.52 - $13.81 $685 - $994
72 Added 1.89%
3,872 $44,000
Q3 2021

Nov 02, 2021

BUY
$11.85 - $17.32 $45,030 - $65,816
3,800 New
3,800 $48,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.22B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.